We are live on ! Find out more
PTJ

Paul Tudor Jones Tudor Investment Corp

AUM $71.9B
1-Year Est. Return 42.37%
 

Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.

This Fund
S&P 500
This Quarter Est. Return
+6.95%
1 Year Est. Return
+42.37%
3 Year Est. Return
+108.76%
5 Year Est. Return
+114.43%
10 Year Est. Return
+640.77%
AUM
$6.46B
AUM Growth
+$1.4B
Cap. Flow
+$1.28B
Cap. Flow %
19.8%
Top 10 Hldgs %
6.83%
Holding
3,136
New
836
Increased
737
Reduced
670
Closed
800

Sector Composition

Rank Sector Weight
1 Technology 16.69%
2 Industrials 11.81%
3 Healthcare 11.19%
4 Financials 10.02%
5 Consumer Discretionary 9.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HON icon
2651
PUT
Honeywell
HON
$68.4B
-11,459
Closed -$2.31M
HOOD icon
2652
Robinhood
HOOD
$97.2B
-244,460
Closed -$1.99M
HPQ icon
2653
HP
HPQ
$27.2B
-12,339
Closed -$332K
HRB icon
2654
CALL
H&R Block
HRB
$6.62B
-14,400
Closed -$526K
HRB icon
2655
PUT
H&R Block
HRB
$6.62B
-15,000
Closed -$549K
HUBB icon
2656
CALL
Hubbell
HUBB
$24.8B
-1,300
Closed -$304K
HUBB icon
2657
PUT
Hubbell
HUBB
$24.8B
-900
Closed -$211K
HUM icon
2658
Humana
HUM
$45.5B
-15,688
Closed -$7.75M
HUM icon
2659
PUT
Humana
HUM
$45.5B
-1,600
Closed -$819K
HUN icon
2660
PUT
Huntsman Corp
HUN
$1.75B
-11,700
Closed -$321K
HURN icon
2661
Huron Consulting
HURN
$2.57B
-11,857
Closed -$861K
HY icon
2662
Hyster-Yale Materials Handling
HY
$622M
-15,985
Closed -$405K
HZO icon
2663
MarineMax
HZO
$1.15B
-27,773
Closed -$867K
IBN icon
2664
ICICI Bank
IBN
$107B
-244,574
Closed -$5.35M
ICE icon
2665
Intercontinental Exchange
ICE
$90.5B
-93,504
Closed -$9.74M
ICLN icon
2666
iShares Global Clean Energy ETF
ICLN
$2.09B
-10,862
Closed -$216K
ICUI icon
2667
ICU Medical
ICUI
$4.57B
-5,097
Closed -$803K
ICUI icon
2668
PUT
ICU Medical
ICUI
$4.57B
-2,200
Closed -$346K
IDXX icon
2669
Idexx Laboratories
IDXX
$43.9B
-11,982
Closed -$5.73M
IIIN icon
2670
Insteel Industries
IIIN
$599M
-10,502
Closed -$289K
IMAX icon
2671
CALL
IMAX
IMAX
$2.89B
-13,300
Closed -$194K
IMAX icon
2672
IMAX
IMAX
$2.89B
-121,643
Closed -$1.78M
INSP icon
2673
CALL
Inspire Medical Systems
INSP
$1.8B
-2,100
Closed -$528K
INTU icon
2674
CALL
Intuit
INTU
$100B
-1,600
Closed -$624K
IPGP icon
2675
IPG Photonics
IPGP
$3.12B
-4,766
Closed -$451K

Similar funds

Paul Tudor Jones's Q1 2023 Portfolio in Review

As of Q1 2023, Paul Tudor Jones held 3,136 positions worth $6.46B, up 28% from $5.06B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.

Paul Tudor Jones deployed $1.28B of net new capital in Q1 2023, opening 836 new positions and adding to 737 existing holdings. Its largest new stake was Johnson & Johnson: 216,183 shares worth $33.5M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $37.7M trimmed.

  • Paul Tudor Jones's largest Q1 2023 buy was Johnson & Johnson: 216,183 shares worth $33.5M.
  • Paul Tudor Jones added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $47.5M increase.
  • Paul Tudor Jones's biggest Q1 2023 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $37.7M.
  • Paul Tudor Jones fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $51.8M.
  • Paul Tudor Jones's ten largest holdings make up 6.8% of its $6.46B portfolio in Q1 2023.
  • Paul Tudor Jones opened 836 new positions and closed 800 in Q1 2023.
  • Paul Tudor Jones's portfolio value rose 28% quarter-over-quarter to $6.46B.

Based on Tudor Investment Corp's 13F filing for Q1 2023, filed 15 May 2023.